Sigyn Therapeutics, Inc.
SIGY
$4.15
$0.153.75%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 56.32% | -38.79% | -13.76% | 35.54% | -29.86% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -6.67% | -59.46% | 3,800.00% |
| Total Amortization of Deferred Charges | -70.20% | 40.08% | 104.58% | -78.27% | 118.28% |
| Total Other Non-Cash Items | -108.96% | 680.00% | 0.00% | 263.04% | -165.90% |
| Change in Net Operating Assets | -60.31% | -1.39% | 6.98% | -26.40% | 102.08% |
| Cash from Operations | -77.17% | 10.39% | 22.41% | -84.21% | 64.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -39.97% | 31.89% | -17.41% | 269.07% | -81.48% |
| Total Debt Repaid | -63.16% | -6.40% | -25.00% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.96% | 35.07% | -20.72% | 242.40% | -81.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.35% | 434.13% | -1.42% | 139.89% | -229.02% |